Global Bio-imaging Market Size and Trends

Global bio-imaging market size is expected to reach US$ 15.58 Bn by 2030, from US$ 5.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 15.3% during the forecast period.

Bio-imaging refers to visualization of biological processes taking place inside living systems at both molecular and macroscopic levels through the use of imaging technologies. Global bio-imaging market has been witnessing steady growth over the forecast period. Factors such as rising geriatric population and advancement in biosciences such as genomics and proteomics are driving demand for imaging modalities to understand complex biological processes.

Global Bio-imaging Market- Trends

Adoption of artificial intelligence (AI) and robotics in bio-imaging systems: Integration of artificial intelligence and robotics in bio-imaging systems is having a significant impact on the global bio-imaging market. The use of AI and machine learning algorithms is allowing bio-imaging systems to automate tasks like image classification, detection of abnormalities, segmentation of images, and predictive diagnosis. For instance, in October 2022, TeraRecon, an industry leader in advanced visualization and artificial intelligence (AI) for medical imaging, launch its next-generation Eureka clinical AI platform. The platform serves as an end-to-end clinical application integrating multiple AI algorithms and workflows.
Development of advanced biochemical and probes: The development of advanced biochemical and probes is significantly influencing the global bio-imaging market. As the research in life sciences deepens, the need for sophisticated tools to visualize biological processes at the molecular, cellular and whole body levels has increased tremendously. Bio-imaging techniques allow researchers to gain novel insights into the functioning of living systems which is crucial for developing diagnostics and therapeutics targeted at various diseases.